Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT03140358
Eligibility Criteria:
Inclusion criteria
1. One parent with myopia (\<-3D in at least one eye)
2. SE +1.00D to -1.50D
3. Astigmatism \< = 1.50D
4. Distance vision logMAR 0.2 or better in both eyes
5. Intraocular pressure of not greater than 21 mmHg
6. No allergy to atropine, cyclopentolate, proparacaine and benzalkonium chloride
Exclusion Criteria:
1. Any eye or systemic disease that affect vision or refractive error
2. Conditions where topical atropine contraindicated
3. Previous use of atropine or pirenzepine
4. Known past/current amblyopia or strabismus
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
9 Years
Study:
NCT03140358
Study Brief:
Protocol Section:
NCT03140358